Compare TREX & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TREX | AMRX |
|---|---|---|
| Founded | 1996 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.0B |
| IPO Year | 1999 | N/A |
| Metric | TREX | AMRX |
|---|---|---|
| Price | $42.99 | $13.28 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 4 |
| Target Price | ★ $52.22 | $13.25 |
| AVG Volume (30 Days) | ★ 1.9M | 1.7M |
| Earning Date | 02-23-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.84 | 0.02 |
| Revenue | $1,180,769,000.00 | ★ $2,934,959,000.00 |
| Revenue This Year | $2.57 | $9.99 |
| Revenue Next Year | $3.81 | $6.67 |
| P/E Ratio | ★ $22.88 | $691.07 |
| Revenue Growth | 0.10 | ★ 9.50 |
| 52 Week Low | $29.77 | $6.69 |
| 52 Week High | $75.55 | $13.49 |
| Indicator | TREX | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 76.53 | 65.48 |
| Support Level | $36.10 | $12.66 |
| Resistance Level | $42.78 | $13.49 |
| Average True Range (ATR) | 1.53 | 0.31 |
| MACD | 0.90 | -0.01 |
| Stochastic Oscillator | 95.14 | 81.82 |
Trex Co Inc is a manufacturer of wooden alternative decking products. The company offers outdoor products in the decking, railing, porch, fencing, trim, steel deck framing, and outdoor lighting categories. Its products are sold under the Trex brand and manufactured in the United States. Further, the company licenses its Trex brand to third parties to manufacture and sell products under the Trex trademark. The distribution is focused on wholesale distributors and retail lumber dealers, which in turn sell Trex products to homeowners and contractors, with an emphasis on professional contractors, remodelers, and homebuilders. The company operates in one reportable segment i.e. Trex Residential.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.